Is this the fabled 6th indication? I assume it is. We were told it was a neurological condition. The resolution with the university of Munster allowed it to progress to a n=6 trial possibly later this year.
Ann: afamelanotide in fair-skinned Parkinsons patients, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.79 |
Change
0.290(2.15%) |
Mkt cap ! $690.5M | |||
| Open | High | Low | Value | Volume |
| $13.50 | $13.98 | $13.40 | $1.675M | 122.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250 | $13.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.89 | 57 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |